newsfilter
← Latest News
ACCESS Newswire·

CASI Pharmaceuticals Announces Second Quarter 2025 Business and Financial Results

SOUTH SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / August 29, 2025 / CASI Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with